YKL-40 serum or plasma levels have been reported to correlate to CSF levels and to be increased not only in amnestic MCI, AD, and non-AD dementia but also in various other conditions, such as cancer, inflammatory diseases, infections, or coronary heart disease [32–34]. The gene discussed is CHI3L1; the disease is Alzheimer disease.